These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11269152)

  • 41. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Lehmann HC; Hughes RA; Hartung HP
    Handb Clin Neurol; 2013; 115():415-27. PubMed ID: 23931793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg.
    Walk D; Li LY; Parry GJ; Day JW
    Neurology; 2004 Jan; 62(1):155-6. PubMed ID: 14718727
    [No Abstract]   [Full Text] [Related]  

  • 43. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Topics of chronic inflammatory demyelinating polyradiculoneuropathy--diagnosis and treatment situation in Japan].
    Iijima M
    Rinsho Byori; 2013 May; 61(5):407-13. PubMed ID: 23947179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrent hypogeusia in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    Kawaguchi N; Sugeno N; Endo K; Miura E; Misu T; Nakashima I; Itoyama Y
    J Clin Neurosci; 2012 Apr; 19(4):604-5. PubMed ID: 22285114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Management and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Results of a French national opinion survey].
    Azulay JP; Puget S; Goulamhoussen N; Pouget J
    Rev Neurol (Paris); 2008 Dec; 164(12):1035-43. PubMed ID: 18808772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
    van Schaik IN; Winer JB; de Haan R; Vermeulen M
    Lancet Neurol; 2002 Dec; 1(8):491-8. PubMed ID: 12849334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term plasma exchange in pediatric CIDP.
    Lucchetta M; Vidal E; Sartori S; Campagnolo M; Torre CD; Marson P; Manara R; Briani C
    J Clin Apher; 2015 Dec; 30(6):364-6. PubMed ID: 25663075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic inflammatory demyelinating polyradiculoneuropathy with ataxia.
    Stockdale RC; Biswas CK
    J R Soc Med; 2004 Jul; 97(7):338-9. PubMed ID: 15229265
    [No Abstract]   [Full Text] [Related]  

  • 51. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Child neurology: chronic inflammatory demyelinating polyradiculoneuropathy in children.
    Markowitz JA; Jeste SS; Kang PB
    Neurology; 2008 Dec; 71(23):e74-8. PubMed ID: 19047554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New insights into the management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Rajabally YA; Blomkwist-Markens PH; Katzberg HD
    Neurodegener Dis Manag; 2015; 5(3):257-68. PubMed ID: 26107324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
    Franques J
    Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen JA; Bril V
    Neurodegener Dis Manag; 2016 Jun; 6(3):237-47. PubMed ID: 27230584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
    Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
    Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
    [No Abstract]   [Full Text] [Related]  

  • 58. [A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange].
    Shimizu M; Koda T; Nakatsuji Y; Ogata H; Kira JI; Mochizuki H
    Rinsho Shinkeigaku; 2017 Jan; 57(1):41-44. PubMed ID: 28025411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic inflammatory demyelinating polyradiculoneuropathy: new views and guidelines.
    Donofrio PD
    J Peripher Nerv Syst; 2005 Sep; 10(3):217-9. PubMed ID: 16221282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.